replaced by new wordings as follows: "Clause 4. Registered Capital 134,476,723.50 Baht (One hundred and thirty-four million, four hundred and seventy- six thousand, seven hundred and twenty-three point five
Eksangkul, and 3) Prof. Dr. Tharapong Vitidsant to resume their positions as the company directors. Remuneration for the year 2019 would not be over than 2.5 million baht (excluding the salary for directors
85.65% of paid-up capital shares. Following this transaction, the Company has acquired a business which operate in the Biopharmaceutical products. 4) the purchase price Total amount of Baht 50 million 3
share capital1 (the “Share Purchase”), at the price of INR 36 per share, equaling to the total investment amount of INR 2,988.00 million (the “Maximum Share Purchase Cost”), or equivalent to approximately
., independent appraiser under the Securities and Exchange Commission approved list, is amounted to approximately Baht 1,500 million. 6) The subsidiary’s debts and other obligations Prior to the Sale and Purchase
.2546 (2003). The Executive Director will receive a monthly remuneration of Baht 315,000 per month from the Company. Total monthly remuneration for 1 year will be Baht 3.78 million. In addition, the
value 0.03% NTA
Injection Not exceed USD 55,000,000 (Approximately Baht 1,685 million) Purpose of investment For the purpose of organization restructuring for the Company’s Brazil subsidiary as well as to be more flexible
assistance are as follows; Type of the Transaction : Connected Transaction Re: the Receipt of Financial Assistance Credit facility : Long-term loan in amount of not more than THB 960 million (no collateral